{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T22:02:25Z","timestamp":1789509745429,"version":"build-2803163510"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.parkreldis.2026.108967","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:42:43Z","timestamp":1788478963000},"page":"108967","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Non-surgical treatment of essential tremor: What's in store?"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7736-3270","authenticated-orcid":false,"given":"Malak","family":"AlMojel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5346-0180","authenticated-orcid":false,"given":"Alfonso","family":"Fasano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2026.108967_bib1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/mds.27121","article-title":"Consensus statement on the classification of tremors. From the task force on tremor of the international parkinson and movement disorder society","volume":"33","author":"Bhatia","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2026.108967_bib2","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16064","article-title":"Treatment patterns in essential tremor: real\u2010world evidence from a United Kingdom and France primary care database","volume":"31","author":"Antonazzo","year":"2024","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.parkreldis.2026.108967_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.891446","article-title":"Essential tremor patients experience significant burden beyond tremor: a systematic literature review","volume":"13","author":"Gerbasi","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.parkreldis.2026.108967_bib4","doi-asserted-by":"crossref","DOI":"10.1007\/s11910-013-0378-8","article-title":"The pathophysiology of essential tremor and parkinson's tremor","volume":"13","author":"Helmich","year":"2013","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.parkreldis.2026.108967_bib5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/brain\/awr301","article-title":"Defective dentate nucleus GABA receptors in essential tremor","volume":"135","author":"Paris-Robidas","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2026.108967_bib6","doi-asserted-by":"crossref","first-page":"254","DOI":"10.5334\/tohm.229","article-title":"The GABA Hypothesis in essential tremor: lights and shadows","volume":"4","author":"Gironell","year":"2014","journal-title":"Tremor. Other Hyperkinet. Mov. (N Y)"},{"key":"10.1016\/j.parkreldis.2026.108967_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.680254","article-title":"Imaging the pathophysiology of essential tremor\u2014A systematic review","volume":"12","author":"Holtbernd","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.parkreldis.2026.108967_bib8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1023\/B:NEUR.0000029648.81071.20","article-title":"Harmaline-induced climbing fiber activation causes amino acid and peptide release in the rodent cerebellar cortex and a unique temporal pattern of Fos expression in the olivo-cerebellar pathway","volume":"33","author":"Beitz","year":"2004","journal-title":"J. Neurocytol."},{"key":"10.1016\/j.parkreldis.2026.108967_bib9","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1152\/jn.00477.2006","article-title":"Cortical involvement in the generation of essential tremor","volume":"97","author":"Raethjen","year":"2007","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.parkreldis.2026.108967_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-73714-9","article-title":"Cerebello-thalamo- cortical network is intrinsically altered in essential tremor: evidence from a resting state functional MRI study","volume":"10","author":"Nicoletti","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.parkreldis.2026.108967_bib11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00401-016-1626-1","article-title":"Climbing fiber-Purkinje cell synaptic pathology in tremor and cerebellar degenerative diseases","volume":"133","author":"Kuo","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.parkreldis.2026.108967_bib12","doi-asserted-by":"crossref","first-page":"15196","DOI":"10.1523\/JNEUROSCI.0934-10.2010","article-title":"Ablation of glutamate receptor GluR\u03b42 in adult purkinje cells causes multiple innervation of climbing fibers by inducing aberrant invasion to parallel fiber innervation territory","volume":"30","author":"Miyazaki","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.parkreldis.2026.108967_bib13","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay1769","article-title":"Cerebellar oscillations driven by synaptic pruning deficits of cerebellar climbing fibers contribute to tremor pathophysiology","volume":"12","author":"Pan","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.parkreldis.2026.108967_bib14","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1001\/archneur.1986.00520010038018","article-title":"Dose-response relationship of propranolol in the treatment of essential tremor","volume":"43","author":"Koller","year":"1986","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.parkreldis.2026.108967_bib15","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/jnnp.49.1.64","article-title":"A comparison of primidone, propranolol, and placebo in essential tremor, using quantitative analysis","volume":"49","author":"Gorman","year":"1986","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"10.1016\/j.parkreldis.2026.108967_bib16","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/mds.27700","article-title":"MDS evidence\u2010based review of treatments for essential tremor","volume":"34","author":"Ferreira","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2026.108967_bib17","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/00002826-200603000-00007","article-title":"A double-blind, placebo-controlled, crossover trial of topiramate in essential tremor","volume":"29","author":"Frima","year":"2006","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.parkreldis.2026.108967_bib18","article-title":"Topiramate for essential tremor","volume":"2017","author":"Bruno","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"issue":"JCNSD","key":"10.1016\/j.parkreldis.2026.108967_bib19","article-title":"Pharmacotherapy of essential tremor","volume":"5","author":"Hedera","year":"2013","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"10.1016\/j.parkreldis.2026.108967_bib20","article-title":"Pregabalin for essential tremor","volume":"2020","author":"Bruno","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.parkreldis.2026.108967_bib21","article-title":"The impact of pregabalin and gabapentin on essential tremor: a systematic review and meta-analysis","volume":"13","author":"Pourbala","year":"2025","journal-title":"Clin. Parkinson. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2026.108967_bib22","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/mds.22418","article-title":"Zonisamide for essential tremor: an evaluator\u2010blinded study","volume":"24","author":"Handforth","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2026.108967_bib23","article-title":"Zonisamide for essential tremor","volume":"2017","author":"Bruno","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.parkreldis.2026.108967_bib24","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejphar.2007.01.067","article-title":"Effects of intrastriatal injections of glutamate receptor antagonists on the severity of paroxysmal dystonia in the dtsz mutant","volume":"563","author":"Sander","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.parkreldis.2026.108967_bib25","article-title":"Safety and efficacy of the AMPA receptor antagonist perampanel for tremors: a systematic review","author":"Manalo","year":"2025","journal-title":"Acta Med. Philipp."},{"key":"10.1016\/j.parkreldis.2026.108967_bib26","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/mdc3.13576","article-title":"Non\u2010persistence of tremorolytic effect of perampanel in essential tremor: real-world experience with 50 patients","volume":"10","author":"Gironell","year":"2022","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.parkreldis.2026.108967_bib27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/WNF.0000000000000541","article-title":"Perampanel: medical alternative for essential tremor?","volume":"46","author":"D\u00edaz-Feliz","year":"2023","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.parkreldis.2026.108967_bib28","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/mds.870110306","article-title":"A randomized, double\u2010blind, placebo\u2010controlled study to evaluate botulinum toxin type A in essential hand tremor","volume":"11","author":"Jankovic","year":"1996","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2026.108967_bib29","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1212\/WNL.56.11.1523","article-title":"A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor","volume":"56","author":"Brin","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2026.108967_bib30","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3390\/toxins14030203","article-title":"Botulinum toxin for essential tremor and hands tremor in the neurological diseases: a meta-analysis of randomized controlled trials","volume":"14","author":"Liao","year":"2022","journal-title":"Toxins"},{"key":"10.1016\/j.parkreldis.2026.108967_bib31","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3390\/toxins16090392","article-title":"Use of botulinum toxin in upper-limb tremor: systematic review and perspectives","volume":"16","author":"Motavasseli","year":"2024","journal-title":"Toxins"},{"key":"10.1016\/j.parkreldis.2026.108967_bib32","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1124\/pr.108.00505","article-title":"International union of pharmacology. LXX. Subtypes of \u03b3- aminobutyric AcidA receptors: classification on the basis of subunit composition, pharmacology, and function. Update","volume":"60","author":"Olsen","year":"2008","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.parkreldis.2026.108967_bib33","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s13311-023-01341-z","article-title":"GABAA receptor subtype specificity in essential tremor","volume":"20","author":"Kuo","year":"2023","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.parkreldis.2026.108967_bib34","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s13311-023-01342-y","article-title":"Cerebellar \u03b16GABAA receptors as a therapeutic target for essential tremor: proof-of-concept study with ethanol and pyrazoloquinolinones","volume":"20","author":"Huang","year":"2023","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.parkreldis.2026.108967_bib35","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3390\/cells13050386","article-title":"Developmental ethanol exposure impacts purkinje cells but not microglia in the young adult cerebellum","volume":"13","author":"Cealie","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.parkreldis.2026.108967_bib36","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0306-4522(00)00442-5","article-title":"GABAA receptors: immunocytochemical distribution of 13 subunits in the adult rat brain","volume":"101","author":"Pirker","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.parkreldis.2026.108967_bib37","article-title":"Search for novel therapies for essential tremor based on positive modulation of \u03b16-Containing GABAA receptors","volume":"13","author":"Handforth","year":"2023","journal-title":"Tremor Hyperkinet. Movement."},{"key":"10.1016\/j.parkreldis.2026.108967_bib38","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0140-6736(18)31551-4","article-title":"Brexanolone injection in post- partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials","volume":"392","author":"Meltzer-Brody","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.parkreldis.2026.108967_bib40","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1001\/jamapsychiatry.2021.1559","article-title":"Effect of zuranolone vs placebo in postpartum depression","volume":"78","author":"Deligiannidis","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.parkreldis.2026.108967_bib45","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s12311-015-0750-0","article-title":"Linking essential tremor to the cerebellum\u2014animal model evidence","volume":"15","author":"Handforth","year":"2016","journal-title":"Cerebellum"},{"key":"10.1016\/j.parkreldis.2026.108967_bib46","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1523\/JNEUROSCI.0290-04.2004","article-title":"Dendritic control of spontaneous bursting in cerebellar purkinje cells","volume":"24","author":"Womack","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.parkreldis.2026.108967_bib47","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/acn3.51735","article-title":"T\u2010type calcium channels as therapeutic targets in essential tremor and Parkinson's disease","volume":"10","author":"Matthews","year":"2023","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.parkreldis.2026.108967_bib50","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1002\/mds.28584","article-title":"A phase 2 Proof\u2010of\u2010Concept, randomized, placebo\u2010controlled trial of <scp>CX<\/scp>\u20108998 in essential tremor","volume":"36","author":"Papapetropoulos","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2026.108967_bib54","article-title":"A phase 2 clinical trial evaluating the efficacy, safety, tolerability, and pharmacokinetics of PRAX-944 in adults with essential tremor","author":"Olhaye Gb","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2026.108967_bib57","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.chembiol.2012.07.013","article-title":"Selective positive modulator of calcium-activated potassium channels exerts beneficial effects in a mouse model of spinocerebellar ataxia type 2","volume":"19","author":"Kasumu","year":"2012","journal-title":"Chem. Biol."},{"key":"10.1016\/j.parkreldis.2026.108967_bib59","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1113\/JP273424","article-title":"Active integration of glutamatergic input to the inferior olive generates bidirectional postsynaptic potentials","volume":"595","author":"Garden","year":"2017","journal-title":"J. Physiol."},{"key":"10.1016\/j.parkreldis.2026.108967_bib60","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1523\/JNEUROSCI.3677-05.2006","article-title":"Block of inferior olive gap junctional coupling decreases purkinje cell complex spike synchrony and rhythmicity","volume":"26","author":"Blenkinsop","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.parkreldis.2026.108967_bib61","article-title":"Modulatory mechanisms of TARP \u03b38-selective AMPA receptor therapeutics","volume":"14","author":"Zhang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.parkreldis.2026.108967_bib63","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3390\/biom12020243","article-title":"Neurobiological and pharmacological perspectives of D3 receptors in parkinson's disease","volume":"12","author":"Chagraoui","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.parkreldis.2026.108967_bib64","first-page":"10753","volume":"103","author":"Jeanneteau","year":"2006"},{"key":"10.1016\/j.parkreldis.2026.108967_bib65","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1007\/s11064-020-03010-5","article-title":"Pramipexole reduces zif-268 mRNA expression in brain structures involved in the generation of harmaline-induced tremor","volume":"45","author":"Kosmowska","year":"2020","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.parkreldis.2026.108967_bib66","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nm1693","article-title":"Adenosine is crucial for deep brain stimulation\u2013 mediated attenuation of tremor","volume":"14","author":"Bekar","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.parkreldis.2026.108967_bib67","doi-asserted-by":"crossref","first-page":"4411","DOI":"10.1093\/cercor\/bhw243","article-title":"Adenosine differentially modulates synaptic transmission of excitatory and inhibitory microcircuits in layer 4 of rat barrel cortex","volume":"27","author":"Qi","year":"2017","journal-title":"Cerebr. Cortex"},{"key":"10.1016\/j.parkreldis.2026.108967_bib68","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.neuroscience.2019.12.045","article-title":"Inhibition of excessive glutamatergic transmission in the ventral thalamic nuclei by a selective adenosine A1 receptor agonist, 5\u2032-Chloro-5\u2032-Deoxy-(\u00b1)-ENBA underlies its tremorolytic effect in the harmaline-induced model of essential tremor","volume":"429","author":"Kosmowska","year":"2020","journal-title":"Neuroscience"},{"key":"10.1016\/j.parkreldis.2026.108967_bib69","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s12640-019-00034-w","article-title":"In vivo evaluation of A1 adenosine agonists as novel anticonvulsant medical countermeasures to nerve agent intoxication in a rat soman seizure model","volume":"36","author":"Thomas","year":"2019","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.parkreldis.2026.108967_bib70","first-page":"14","article-title":"Double-blind, randomized, Placebo- controlled, crossover study of oral cannabidiol and tetrahydrocannabinol for essential tremor","volume":"15","author":"Longardner","year":"2025","journal-title":"Tremor. Other Hyperkinet. Mov. (N Y)"},{"key":"10.1016\/j.parkreldis.2026.108967_bib71","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.brs.2023.12.007","article-title":"Transcranial focused ultrasound for the treatment of tremor: a preliminary case series","volume":"17","author":"Deveney","year":"2024","journal-title":"Brain Stimul."},{"key":"10.1016\/j.parkreldis.2026.108967_bib72","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1113\/jphysiol.2010.196998","article-title":"Boosting brain excitability by transcranial high frequency stimulation in the ripple range","volume":"588","author":"Moliadze","year":"2010","journal-title":"J. Physiol."},{"key":"10.1016\/j.parkreldis.2026.108967_bib73","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s13311-023-01372-6","article-title":"Cerebellar transcranial alternating current stimulation in essential tremor patients with thalamic stimulation: a proof-of-concept study","volume":"20","author":"Olivier","year":"2023","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.parkreldis.2026.108967_bib74","doi-asserted-by":"crossref","first-page":"29","DOI":"10.5334\/tohm.775","article-title":"Transcutaneous afferent patterned stimulation for essential tremor: real-world evidence with long term Follow-Up","volume":"13","author":"Lu","year":"2023","journal-title":"Tremor Hyperkinet. Movement."},{"key":"10.1016\/j.parkreldis.2026.108967_bib75","article-title":"Real-world evidence of transcutaneous afferent patterned stimulation for essential tremor","volume":"12","author":"Brillman","year":"2022","journal-title":"Tremor Hyperkinet. Movement."},{"key":"10.1016\/j.parkreldis.2026.108967_bib76","doi-asserted-by":"crossref","first-page":"29","DOI":"10.5334\/tohm.59","article-title":"Prospective home-use study on non-invasive neuromodulation therapy for essential tremor","volume":"10","author":"Isaacson","year":"2020","journal-title":"Tremor Hyperkinet. Movement."},{"key":"10.1016\/j.parkreldis.2026.108967_bib77","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.brs.2025.06.004","article-title":"Wearable peripheral nerve stimulator reduces essential tremor symptoms through targeted brain modulation","volume":"18","author":"Luu","year":"2025","journal-title":"Brain Stimul."},{"key":"10.1016\/j.parkreldis.2026.108967_bib78","article-title":"A pilot study of AI-Controlled transcutaneous peripheral nerve stimulation for essential tremor","volume":"15","author":"Dewey","year":"2025","journal-title":"Tremor Hyperkinet. Movement."},{"key":"10.1016\/j.parkreldis.2026.108967_bib79","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1001\/jamaneurol.2025.3905","article-title":"Transcutaneous peripheral nerve stimulation for essential tremor: a randomized clinical trial","volume":"82","author":"Ondo","year":"2025","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.parkreldis.2026.108967_bib80","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF02368521","article-title":"Attenuation of pathological tremors by functional electrical stimulation I: method","volume":"20","author":"Prochazka","year":"1992","journal-title":"Ann. Biomed. Eng."},{"key":"10.1016\/j.parkreldis.2026.108967_bib81","doi-asserted-by":"crossref","DOI":"10.1186\/s12984-021-00811-9","article-title":"Peripheral electrical stimulation to reduce pathological tremor: a review","volume":"18","author":"Pascual-Valdunciel","year":"2021","journal-title":"J. NeuroEng. Rehabil."},{"key":"10.1016\/j.parkreldis.2026.108967_bib82","doi-asserted-by":"crossref","DOI":"10.3389\/fnhum.2021.622535","article-title":"Tremor-suppression orthoses for the upper limb: current developments and future challenges","volume":"15","author":"Nguyen","year":"2021","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.parkreldis.2026.108967_bib83","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/mdc3.13492","article-title":"Therapies, research funding, and racial diversity in essential tremor: a systematic review of the literature","volume":"9","author":"Zesiewicz","year":"2022","journal-title":"Mov. Disord. Clin. Pract."},{"issue":"4","key":"10.1016\/j.parkreldis.2026.108967_bib84","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/mds.70184","article-title":"Update on medical treatments for essential tremor: an international parkinson and movement disorder society evidence-based medicine review","volume":"41","author":"Dash","year":"2026","journal-title":"Mov. Disord."},{"issue":"11","key":"10.1016\/j.parkreldis.2026.108967_bib85","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1002\/mdc3.70147","article-title":"Current and emerging therapeutic targets for essential tremor: a critical appraisal of recent preclinical and clinical studies","volume":"12","author":"Mukherjee","year":"2025","journal-title":"Mov. Disord. Clin. Pract."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802026007947?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802026007947?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:06:37Z","timestamp":1789506397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802026007947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":71,"alternative-id":["S1353802026007947"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2026.108967","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-surgical treatment of essential tremor: What's in store?","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2026.108967","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108967"}}